1. Home
  2. PULM vs RAYA Comparison

PULM vs RAYA Comparison

Compare PULM & RAYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PULM
  • RAYA
  • Stock Information
  • Founded
  • PULM 2003
  • RAYA 2019
  • Country
  • PULM United States
  • RAYA China
  • Employees
  • PULM N/A
  • RAYA N/A
  • Industry
  • PULM Biotechnology: Pharmaceutical Preparations
  • RAYA Metal Fabrications
  • Sector
  • PULM Health Care
  • RAYA Consumer Discretionary
  • Exchange
  • PULM Nasdaq
  • RAYA Nasdaq
  • Market Cap
  • PULM 30.9M
  • RAYA 34.2M
  • IPO Year
  • PULM N/A
  • RAYA 2022
  • Fundamental
  • Price
  • PULM $6.20
  • RAYA $1.41
  • Analyst Decision
  • PULM
  • RAYA
  • Analyst Count
  • PULM 0
  • RAYA 0
  • Target Price
  • PULM N/A
  • RAYA N/A
  • AVG Volume (30 Days)
  • PULM 8.4K
  • RAYA 21.4K
  • Earning Date
  • PULM 05-20-2025
  • RAYA 01-01-0001
  • Dividend Yield
  • PULM N/A
  • RAYA N/A
  • EPS Growth
  • PULM N/A
  • RAYA N/A
  • EPS
  • PULM N/A
  • RAYA N/A
  • Revenue
  • PULM $7,806,000.00
  • RAYA $30,300,360.00
  • Revenue This Year
  • PULM N/A
  • RAYA $20.95
  • Revenue Next Year
  • PULM $134.88
  • RAYA N/A
  • P/E Ratio
  • PULM N/A
  • RAYA N/A
  • Revenue Growth
  • PULM 6.96
  • RAYA 49.10
  • 52 Week Low
  • PULM $1.72
  • RAYA $0.56
  • 52 Week High
  • PULM $10.40
  • RAYA $1.90
  • Technical
  • Relative Strength Index (RSI)
  • PULM 46.38
  • RAYA 49.05
  • Support Level
  • PULM $5.88
  • RAYA $1.23
  • Resistance Level
  • PULM $6.85
  • RAYA $1.59
  • Average True Range (ATR)
  • PULM 0.30
  • RAYA 0.15
  • MACD
  • PULM 0.02
  • RAYA -0.03
  • Stochastic Oscillator
  • PULM 30.93
  • RAYA 33.96

About PULM Pulmatrix Inc.

Pulmatrix Inc is a clinical-stage biotechnology company. The company is focused on the discovery and development of novel inhaled therapeutic products intended to prevent and treat respiratory diseases and infections with significant unmet medical needs. Pulmatrix designs and develops inhaled therapeutic products based on its proprietary dry powder delivery technology, iSPERSE (inhaled Small Particles Easily Respirable and Emitted), which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. The iSPERSE powders are engineered to be small, dense particles with dispersibility and delivery to airways.

About RAYA Erayak Power Solution Group Inc.

Erayak Power Solution Group Inc engages in manufacturing, research and development, and wholesale and retail of power solution products. Its product portfolio includes sine wave and off-grid inverters, inverter and gasoline generators, battery, and smart chargers, and custom-designed products. It derives the majority revenue from three products namely inverters, chargers, and gasoline generators. The company geographically operates in China, Australia, Poland, U.K., and Germany. It derives maximum revenue from China.

Share on Social Networks: